![[ Visit WOCN Website ]](images/banner09.jpg)
COMPARISON OF WOUNDS TREATED WITH AN AUTOLOGUS BLOOD-DERIVED TISSUE GRAFT PROTOCOL VERSES COST TO TREAT WITH NEGATIVE PRESSURE
The properly implanted autologous graft converts a chronic wound to an acute one by using the patient’s own platelets, growth factors, bacteriostatic leukocytes and catalytic stem cells embodied in a fibrin/collagen matrix to re-initiate and modulate the healing cascade of regranulation, angiogenesis and wound closure.
Negative pressure assists wound healing by reducing edema, promoting granulation tissue, promoting perfusion, drawing the edges of the wound together, removing exudate and infectious materials.
Twenty-two patients with thirty-one various wound types were evaluated over a three week period. Wound types included pressure, dehisced surgical, and diabetic. Beginning and ending wound volumes were recorded and the cost to treat for three weeks with negative pressure verses SABTG was compared. The negative pressure evaluation criteria were the actual cost of the pump rental plus three dressings and one canister per week for three weeks. The autologous blood-derived tissue graft evaluation criteria were the actual cost of the kit for the procedure. Costs associated with nursing time for monitoring or replacing dressings, repairing leaks to the negative pressure dressings, and the weekly dressing change for the graft were not included.
The evaluation outcomes demonstrated a 71.25% reduction in the volume of the wounds treated with the autologous blood-derived tissue graft and a projected cost savings of 63% over wounds treated with negative pressure therapy.
The properly implanted autologous graft converts a chronic wound to an acute one by using the patient’s own platelets, growth factors, bacteriostatic leukocytes and catalytic stem cells embodied in a fibrin/collagen matrix to re-initiate and modulate the healing cascade of regranulation, angiogenesis and wound closure.
Negative pressure assists wound healing by reducing edema, promoting granulation tissue, promoting perfusion, drawing the edges of the wound together, removing exudate and infectious materials.
Twenty-two patients with thirty-one various wound types were evaluated over a three week period. Wound types included pressure, dehisced surgical, and diabetic. Beginning and ending wound volumes were recorded and the cost to treat for three weeks with negative pressure verses SABTG was compared. The negative pressure evaluation criteria were the actual cost of the pump rental plus three dressings and one canister per week for three weeks. The autologous blood-derived tissue graft evaluation criteria were the actual cost of the kit for the procedure. Costs associated with nursing time for monitoring or replacing dressings, repairing leaks to the negative pressure dressings, and the weekly dressing change for the graft were not included.
The evaluation outcomes demonstrated a 71.25% reduction in the volume of the wounds treated with the autologous blood-derived tissue graft and a projected cost savings of 63% over wounds treated with negative pressure therapy.